{"ticker": {"uuid": "6fa2c68d-c5c4-4574-b77f-76fa6724e4bc", "symbol": "ICUI", "name": "ICU Medical Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Instruments & Supplies"}, "articles": [{"title": "Analyst Report: ICU Medical, Inc.", "summary": "", "url": "https://finance.yahoo.com/m/111bf1e1-524c-35e6-8dc9-ad87ea4d3556/analyst-report%3A-icu-medical%2C.html", "source_name": "Morningstar Research", "published_at": "2026-07-16T18:36:29+00:00", "published_display": "16 Jul 2026 18:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical stock hits 52-week high at 162.53 USD By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPeWh0bjEwTWtaSTM3Mjk1aVF2SThRbkxFSDhPakZkanEycHA1dmpOZjNfLUN6anNRTUJZcDM5SkxMTzBRcndYREFlSVc5eUNxOVMxWnhLcFByN2NWZUJtdnBOUjdLalZIYUZuVkhRTXg3eWRJV3dRYXpMdVdHeWxNNDFHY29zSjFTdXVUZXI2TWExM3cyeFR1MElLZDlsNmJMNlR4NjhYSkk4S3pM?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-16T17:42:53+00:00", "published_display": "16 Jul 2026 17:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Improved Focus and More-Profitable Business Mix Narrate No-Moat ICU Medical's Turnaround Story", "summary": "ICU Medical, originating as an infusion consumables supplier, diversified its product portfolio through key acquisitions, notably Hospira Infusion Systems in 2017 and Smiths Medical in 2022. These strategic moves broadened its offerings to include infusion pumps and IV solutions,", "url": "https://www.morningstar.com/company-reports/1488122-improved-focus-and-more-profitable-business-mix-narrate-no-moat-icu-medicals-turnaround-story", "source_name": "Morningstar", "published_at": "2026-07-16T18:11:03", "published_display": "16 Jul 2026 18:11", "sentiment": "positive", "sentiment_pct": 74, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical stock hits 52-week high at 162.53 USD", "summary": "ICU Medical Inc. (ICUI) stock reached a new 52-week high of $162.18, reflecting a significant 27.93% increase over the past year. InvestingPro analysis suggests the stock is currently undervalued, with a PEG ratio of 0.57, highlighting strong investor confidence and growth potent", "url": "https://www.investing.com/news/company-news/icu-medical-stock-hits-52week-high-at-16253-usd-93CH-4796028", "source_name": "Investing.com", "published_at": "2026-07-16T13:42:41", "published_display": "16 Jul 2026 13:42", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will US$500 Million Non-DEHP IV Expansion in Texas Change ICU Medical's (ICUI) Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-15T20:47:51+00:00", "published_display": "15 Jul 2026 20:47", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pharmaceutical venture announces $500M expansion in Northwest Austin", "summary": "Otsuka ICU Medical LLC is investing $500 million to expand its manufacturing facilities in Austin. This expansion includes a new 500,000-square-foot facility and upgrades to its existing 700,000-square-foot site, aiming to improve the long-term supply of IV solutions and support ", "url": "https://communityimpact.com/northwest-austin/development/pharmaceutical-venture-announces-500m-expansion-in-northwest-austin/", "source_name": "Community Impact", "published_at": "2026-07-14T03:12:22", "published_display": "14 Jul 2026 03:12", "sentiment": "positive", "sentiment_pct": 72, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (ICUI) Short Interest & Short Float | Updated Jul 2026 $ICUI", "summary": "As of June 30, 2026, ICU Medical (ICUI) had a short interest of 1.69 million shares, marking a 4.94% decrease from the previous report, representing 6.89% of the public float. The short interest ratio is 4.6 days to cover, indicating it would take 4.6 days to cover all short posi", "url": "https://www.marketbeat.com/stocks/NASDAQ/ICUI/short-interest/", "source_name": "MarketBeat", "published_at": "2026-07-10T18:40:08", "published_display": "10 Jul 2026 18:40", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Otsuka ICU Medical outlays $500m to expand US manufacturing footprint", "summary": "Otsuka ICU Medical is investing $500 million to expand its US-based IV manufacturing capabilities, including a new 500,000-square-foot facility and upgrades to an existing 700,000-square-foot site in Austin, Texas. This expansion aims to enhance supply reliability for North Ameri", "url": "https://finance.yahoo.com/healthcare/articles/otsuka-icu-medical-outlays-500m-153152237.html", "source_name": "Market source", "published_at": "2026-07-10T15:40:43", "published_display": "10 Jul 2026 15:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does ICU Medical\u2019s (ICUI) Russell Index Exit Quietly Reshape Its Institutional Ownership Story?", "summary": "ICU Medical (ICUI) was removed from several Russell growth and small-cap indexes in June 2026, which may alter trading flows and reshape its institutional ownership. While the core business of infusion therapies remains, the company faces ongoing regulatory risks and product reca", "url": "https://www.sahmcapital.com/news/content/does-icu-medicals-icui-russell-index-exit-quietly-reshape-its-institutional-ownership-story-2026-07-08", "source_name": "Sahm", "published_at": "2026-07-10T05:41:39", "published_display": "10 Jul 2026 05:41", "sentiment": "negative", "sentiment_pct": 37, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical Inc (ICUI) Stock Up 3.2% but GF Value Says Overvalued -- GF Score: 80/100", "summary": "ICU Medical Inc (ICUI) stock rose 3.2% to $156.52, but GuruFocus' GF Value\u2122 indicates it is 30.1% overvalued with an intrinsic value of $120.31. Despite a strong GF Score\u2122 of 80/100, highlighting good profitability and growth, its financial strength and valuation ranks are modera", "url": "https://www.gurufocus.com/news/8952715/icu-medical-inc-icui-stock-up-32-but-gf-value-says-overvalued-gf-score-80100", "source_name": "GuruFocus", "published_at": "2026-07-09T23:40:24", "published_display": "09 Jul 2026 23:40", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Otsuka ICU Medical LLC Announces Over $500M Expansion of IV Solutions Manufacturing in North America", "summary": "Otsuka ICU Medical LLC is investing over $500 million to expand its IV solutions manufacturing in North America, with a new 500,000-square-foot facility and upgrades to existing operations in Austin, Texas. This expansion aims to enhance supply chain resiliency, accelerate the de", "url": "https://www.tradingview.com/news/prnewswire:a6f67f13363f4:0-otsuka-icu-medical-llc-announces-over-500m-expansion-of-iv-solutions-manufacturing-in-north-america/", "source_name": "TradingView", "published_at": "2026-07-09T16:40:43", "published_display": "09 Jul 2026 16:40", "sentiment": "positive", "sentiment_pct": 74, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Otsuka ICU Medical LLC Announces Over $500 Million Expansion Of IV Solutions Manufacturing In North America", "summary": "Otsuka ICU Medical LLC is investing over $500 million to expand its North American IV solutions manufacturing capabilities, including a new 500,000-square-foot facility in Austin, Texas, and upgrades to existing operations. This expansion aims to enhance supply resiliency, accele", "url": "https://www.marketscreener.com/news/otsuka-icu-medical-llc-announces-over-500-million-expansion-of-iv-solutions-manufacturing-in-north-ce7f5ededb89ff2d", "source_name": "www.marketscreener.com", "published_at": "2026-07-09T14:10:42", "published_display": "09 Jul 2026 14:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Otsuka ICU Medical announces $500M+ Texas manufacturing expansion", "summary": "Otsuka ICU Medical LLC is investing over $500 million to expand its manufacturing operations in Austin, Texas, adding a new 500,000-square-foot facility to increase production of intravenous solutions and support non-DEHP IV solution development for North America. This expansion,", "url": "https://www.investing.com/news/company-news/otsuka-icu-medical-announces-500m-texas-manufacturing-expansion-93CH-4784115", "source_name": "Investing.com", "published_at": "2026-07-09T13:10:42", "published_display": "09 Jul 2026 13:10", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How ICU Medical plans to shore up U.S. IV solution supply", "summary": "Otsuka ICU Medical LLC, a joint venture involving ICU Medical (Nasdaq: ICUI), announced a $500 million expansion for its IV solutions manufacturing in Austin, Texas. This investment includes a new 500,000-square-foot facility and upgrades to the existing 700,000-square-foot site,", "url": "https://www.stocktitan.net/news/ICUI/otsuka-icu-medical-llc-announces-over-500m-expansion-of-iv-solutions-b1nm4h5g4icb.html", "source_name": "Stock Titan", "published_at": "2026-07-09T12:10:42", "published_display": "09 Jul 2026 12:10", "sentiment": "positive", "sentiment_pct": 73, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Responsive Playbooks and the ICUI Inflection", "summary": "This article analyzes Icu Medical Inc. (NASDAQ: ICUI) with a focus on its near, mid, and long-term sentiment and potential price movements. Utilizing AI models, it outlines distinct trading strategies including position, momentum breakout, and risk hedging, complete with entry zo", "url": "https://news.stocktradersdaily.com/news_release/139/Responsive_Playbooks_and_the_ICUI_Inflection_070826022402_1783491842.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-08T02:24:00", "published_display": "08 Jul 2026 02:24", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is ICU Medical (ICUI) Undervalued As Russell Index Removal Triggers Rebalancing?", "summary": "ICU Medical (ICUI) was recently removed from several Russell growth indexes, prompting a re-evaluation of its stock. Despite this, the stock has shown recent firm trading and is considered undervalued by some metrics, with an intrinsic discount and an average analyst price target", "url": "https://www.sahmcapital.com/news/content/is-icu-medical-icui-undervalued-as-russell-index-removal-triggers-rebalancing-2026-07-06", "source_name": "Sahm", "published_at": "2026-07-06T16:40:43", "published_display": "06 Jul 2026 16:40", "sentiment": "positive", "sentiment_pct": 63, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical Inc business profile and stock context", "summary": "ICU Medical Inc is a global medical technology company listed on Nasdaq, specializing in the design, manufacture, and sale of infusion systems and medical devices used in hospitals and clinical settings. The company focuses on improving the safety and efficiency of intravenous th", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/icu-medical-inc-business-profile-and-stock-context/69683033", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-03T20:40:25", "published_display": "03 Jul 2026 20:40", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of ICU Medical, Inc. \u2013 NASDAQ:ICUI", "summary": "This article displays the \"Price to book forward\" financial metric for ICU Medical, Inc. (NASDAQ: ICUI) on TradingView. It presents a value and change percentage for this specific period. The content is primarily a data display page rather than an analytical article.", "url": "https://www.tradingview.com/symbols/NASDAQ-ICUI/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-30T16:13:53", "published_display": "30 Jun 2026 16:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does ICU Medical\u2019s (ICUI) Russell Growth Exit Hint at a Shifting Long-Term Portfolio Role?", "summary": "ICU Medical, Inc. (ICUI) was removed from several Russell growth indices in late June 2026, which could impact its trading volume and portfolio positioning for growth-focused funds. While this creates short-term noise, the company's investment narrative still centers on long-term", "url": "https://www.sahmcapital.com/news/content/does-icu-medicals-icui-russell-growth-exit-hint-at-a-shifting-long-term-portfolio-role-2026-06-29", "source_name": "Sahm", "published_at": "2026-06-30T16:13:53", "published_display": "30 Jun 2026 16:13", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of ICU Medical, Inc. \u2013 NASDAQ:ICUI", "summary": "This article displays the forward price-to-sales ratio for ICU Medical, Inc. (NASDAQ: ICUI). It presents the current value and its change over a period, accessible through TradingView. The content primarily focuses on financial data for the company.", "url": "https://www.tradingview.com/symbols/NASDAQ-ICUI/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T19:10:56", "published_display": "27 Jun 2026 19:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of ICU Medical, Inc. \u2013 NASDAQ:ICUI", "summary": "This article provides the forward price-to-earnings ratio for ICU Medical, Inc. (NASDAQ: ICUI). It is presented as part of a financial overview on TradingView, indicating the company's valuation based on future earnings estimates. The content itself is very brief, showing \"Period", "url": "https://www.tradingview.com/symbols/NASDAQ-ICUI/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T10:10:56", "published_display": "27 Jun 2026 10:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of ICU Medical, Inc. \u2013 DUS:IC7", "summary": "This article provides financial data for ICU Medical, Inc. under the stock symbol IC7 on the Dusseldorf Stock Exchange. It specifically highlights the \"Price to earnings forward\" metric. The page is part of a larger financial data platform by TradingView.", "url": "https://www.tradingview.com/symbols/DUS-IC7/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T08:40:08", "published_display": "27 Jun 2026 08:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of ICU Medical, Inc. \u2013 NASDAQ:ICUI", "summary": "This article provides the enterprise value to EBITDA forward for ICU Medical, Inc. (NASDAQ: ICUI). It appears to be a financial data point from TradingView, indicating a specific valuation metric for the company. The page focuses on the financial data rather than providing a deta", "url": "https://www.tradingview.com/symbols/NASDAQ-ICUI/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T06:40:08", "published_display": "27 Jun 2026 06:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Understanding the Setup: (ICUI) and Scalable Risk", "summary": "Icu Medical Inc. (NASDAQ: ICUI) is exhibiting a mid-channel oscillation pattern with strong near and mid-term sentiment that could extend long-term. An exceptional 35.6:1 risk-reward short setup targets a 10.4% downside with only 0.3% risk. AI models have generated distinct tradi", "url": "https://news.stocktradersdaily.com/news_release/149/Understanding_the_Setup:_ICUI_and_Scalable_Risk_062726011601_1782537361.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-27T01:40:08", "published_display": "27 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICUI Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for ICU Medical, Inc. (ICUI), detailing analyst opinions, historical stock performance, and key financial metrics. It highlights the current stock price, volatility, market capitalization, and upcoming earnings report, along with ", "url": "https://www.tradingview.com/symbols/NASDAQ-ICUI/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T12:39:25", "published_display": "26 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (ICUI) Stock Forum and Discussion", "summary": "This document appears to be a stub or an empty placeholder for a stock forum and discussion about ICU Medical (ICUI). There is no actual content provided beyond the title. The purpose is likely to host future discussions or information related to ICUI stock.", "url": "https://www.moomoo.com/stock/ICUI-US/community?chain_id=Name1K9-3FXPhg.1kvafk0&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A59,%22f%22%3A%22www.moomoo.com%2Foptions%2FSHEL260501P50000-US%22%7D", "source_name": "Moomoo", "published_at": "2026-06-25T13:10:39", "published_display": "25 Jun 2026 13:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (ICUI): Buy, Sell, or Hold Post Q1 Earnings?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxPUnM3WjBFYzVySERDVmI0TjFlTC13anlITGhUZTQ3Um9Fam9haWEyZzVCZUZRbUZ4d2hxYjgyU1YyMTVtVGVUOW1FZFB6bkpCMXRTMGJsLW1DSGRDM3VHTW5aeG5nbXZYVHBLRHk0VHdReGFhaXVqckpEdzliMjY2dWJBdm44alBfMjlPSlpfRzBtM3Jn?oc=5", "source_name": "Market source", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Moody\u2019s upgrades ICU Medical rating to Ba3 on leverage outlook By Investing.com", "summary": "Moody's Ratings has upgraded ICU Medical, Inc. (NASDAQ:ICUI) to Ba3 from B1, anticipating a decline in the company's financial leverage over the next 12 months. This upgrade is based on expectations of adjusted debt to EBITDA remaining below 4.0x, driven by revenue growth, strong", "url": "https://ng.investing.com/news/stock-market-news/moodys-upgrades-icu-medical-rating-to-ba3-on-leverage-outlook-93CH-2563649", "source_name": "Investing.com Nigeria", "published_at": "2026-06-17T20:50:00", "published_display": "17 Jun 2026 20:50", "sentiment": "positive", "sentiment_pct": 72, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BTIG Initiates ICU Medical at Buy With $170 Price Target", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/btig-initiates-icu-medical-buy-102610105.html", "source_name": "MT Newswires", "published_at": "2026-06-15T10:26:10+00:00", "published_display": "15 Jun 2026 10:26", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (ICUI) Stock Valuation Check After Recent Momentum And Discount To Estimated Fair Value", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQeDZjdVU3Ulh0dHViWVpRdk1OdnpFSlhkZjZwMTdSeUdBdVBYSWN0ZGFEZHFEaVk4UmsybW1uRklVZmtoZ19UMFhsLUZvZTVyWUlVbDZwNmFBT1N2UExGMkVnZ0pCNVFtMlZBZ3M5SGc2UDY4Qm9DYnpoUHdJeThScTVlUnY5Q05PdGdsXzh0YlZ4MWpOUDMzZVFQMlJRZw?oc=5", "source_name": "Market source", "published_at": "2026-06-14T07:00:00+00:00", "published_display": "14 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (ICUI) Strengthens Amid Competitors\u2019 Quality Issues", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxORzhuU1JwQmdYRnFYX2pma2VVa0lmN29sbVpuZTBKYkJ5d2xMQmJDM2RUOWd5Tk0tOTBLay12SjVkSUd0c3BiUWhsTFF1ZWpDUmlsWFkyTWxxdzVacTE5cVhHcmxzZEMwaU9CMDQ0QlQxb1QwU01PeHRoZVFlSGxDLUJwVWJxU1hyMUlxYXlEbEkyV3dxeExVVUk5X0JLVTJsZFlaZg?oc=5", "source_name": "Market source", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (ICUI) VP and General Counsel Sanzone sells 2,447 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOaTV3c0p3WmpMcTczalBSVjBjeXRHOGtNdHBBWU5vRmV6N1ViN25yVnFZRjAzRjVySW4wcUJzVG9BU1h3ZHpJTEdzU2dkYzJwUnJKb0Q5OC1IRkR4Y2RHcC1XTi1KMXRpWTNsMVI0cV8tcjBFNzI5akJuUkotTGRqQS1OODZPZ1ZITHVJUVRrQzRjTkgtbWxMNDU0SDNFcWNoazZFa0ttNm1PUDZCc3JIUkh3?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical's (NASDAQ:ICUI) Shareholders May Want To Dig Deeper Than Statutory Profit", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNWUdKNlF5SGQwa3M1R1Q3X2daV3FSSlhob0JrbHY1MXMxekc3WVdyczg2YzhVZWVOZTRWU0htRnZXc2w2NUE2QVRfT1E3cjJ4VGRjdXhTeUtfdVlVejh6ZlNUaG5tVURDWWRCMmtaZlZINGxSQlhwQ0VFM1VvOC01UFg0V1AtTW8wMzdHd3llakJoQzNX?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should ICU Medical\u2019s Q1 Earnings Beat And Return To Profitability Require Action From ICUI Investors?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPV3k5WUYzRnpQaGFYdTRLTWhEZE9OU19RVHVoX1J5V2VoR3JHTmc2YjFlTG5UWnJrNWNOT2JJbkdUT2FlendFV2g2eFFzN2t5TFktT2JjYjFHUXM1YzVidlNPNHRxaEd0SU9LZmdYRlBtT3J5SGV2MnNScUx1bFdlY19wcm1xTFNuczlxcERWbVFGUUc4RGNTaw?oc=5", "source_name": "Market source", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (ICUI) Margins Return To Breakeven Trailing Profit Challenging Bearish Narratives", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxOUnNHUlB4WEhtNlNzMFg3VHhXcmhjalU4eGhadFEyMUlDNUlIWDVqcWRhVVNEdlhKYjJmVDRPMmxwV2VxeGFBRU5HWTFTVGNuMkJTSnNIcGc2cUpDTG4wMExGQmVUREZuYzB1NkdJRFAtRU9hTTEwWm9OQTBVS0NMTVV3YzA0T3hPbzBxeWZHUWxmdmRXZFNaRUZrWWZKVG9QZ2NCOU9Ta00tVE5GSjVkcXN0WVU4M1Y4Ny1TYTZ1WlNhNEJVXy00UF95Vm_SAdIBQVVfeXFMT2xSeEJzSTNFNGY3Tm5GbjZUbXVEZEFodDRXSkREbzVMQUlGei00M01BdFU4NG9MRmdCbnZtWjZhSWNnUjlyQVM5QzFqd2E5WkRCYjJURV84T2haSFkxT2hPTmtVUWVrWEgwclJWNDdhSmxEcTU3UEVMeEZ1ZkdiczBRbFdkekVUV1Q2dktxOGl0b21KSVp3c3EtVjZ6OC10WVZxQUM1REltS1ZCMFBwUUowSDM5c2tWRFY0bWVzSE1VUzlpdVJYb3dCLWZ3REVVVUln?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (NASDAQ:ICUI) Exceeds Q1 CY2026 Expectations", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPdkV3eUQ2SDdXUjdvLTRIOTNnV1FHNmJGNGw3S2taN25jZzU4dmR2NjJwQnhBal9tbHFtbGVLODhDMnlEWm9hNmpKbXgxQnVoU0NEZkFEUW90ZGp6RWxGUm0zV1FfQVhtc3FiNG54Y0V3MktXci1mcnBGTmkySk9XTEFtaTF6d0JrRUE5OTlKNVJjQlptYko4bzdPVkVXZzA0WjREQkFnT25kbGc2dzZMYi1R?oc=5", "source_name": "StockStory", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (ICUI) Tops Q1 Earnings and Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOMHZhOWJhTGNOYlFHazhRaW1Cb3I1M01IQVFrZExhRk8tTWk3QmM3MFFnSXBGV1lIRXIxeVluRk1EaERHdTUzVHRZSEFyRzZLVmJCRVJlS0RTWlFyakRqNWExVDUzSm1ZUWxVZkxSdzdmWk5HV1o0MzQwY2d1S1RGUTBjOTlNeVc3dkQwd2NyYk9VMFZEUmt6LQ?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (ICUI) Reports Next Week: Wall Street Expects Earnings Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQbzBJT3c3X3RKczlqVkpoLVY4MGdVZXN4VnlnWkZycWx3XzdiVlNhTTNaTjE3N005TGJEWVgyNTM0d2hVYTlsdUQxZU1za1pHVm5SR3pkWUtyaHMyU3VVSWJsWXhKVWMydllsVjYtdG41aWpDX3MzR0RWa2pxNXRBcldaMDFrWk1sVnpKb21xRnlYUzFROUpmbDN3?oc=5", "source_name": "Market source", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical posts first-quarter results May 7; call starts at 4:30 ET", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNMzRBRVFNRERXZDItVy1VWjZKSEtVOHhxeGdDMDQwbGlVeF92R3hxVE5VU2pGanNQcE9tM3hja0RocjJma3JSaWJfTmxvdXBLWG1mMnQwQmtPVDcwMkJCNEZnVHhxMVNmWjlYWUhiMXBWSjc2Q2hJUGtManFGaV90WXh0S3ZmTExfbm1xWVFlRWJld01jV3BrNFlwdWtLR0w3U3MydnJOTGZ2Tk9wdDZHR1VOcW5hSm1CM1p6ZDZ4ck4?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The ICU Medical (ICUI) Investment Story Is Evolving With 2026 Guidance And Analyst Targets", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNbjZJTWNZcnZmbnJhMXRPOWFMMFNuQ2xYQ3o3N1hDUTVuNVdicDNPeGxMdkl4ZFNiV08zNGY3OXFfOVFuU3diRXZCSTZ4NUVzVHd0blNSYWwwXzVxUzJoV3J4RUdCUkdfNnJQeURoUEhCNnBITHc2dk5FVXNGWkxIcEZ4dm9lSHU4QzQ1Y2lBaXMwS1AzQWNiM3B1dFBUdmc?oc=5", "source_name": "Market source", "published_at": "2026-03-22T07:00:00+00:00", "published_display": "22 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical Confronts Revenue Strain As Valuation Signals Potential Upside", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-13T07:00:00+00:00", "published_display": "13 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Healthcare Stocks Review 2026: ICU Medical vs. Intuitive Surgical vs. Medpace - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNM0RhNGlxVnltcFNaeDQ1cGV0YThXYm1GWmVUVWxocmFUTVh0eFJWSmFDaTJkSE9sbjhrYjNRVUFfTFE2M0h2SDRwZ0pEYld5MjRVRlJlMER0VUN6M2dJei1GbEtRWHdXSzd5LVBhd1FMYmpVQXlVUkRKdDFISDY5b240dWtCTndGcW1Kck1xN0xpb1N6NmJqTkxxWFEtcHZK?oc=5", "source_name": "IndexBox", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical\u2019s (NASDAQ:ICUI) Q4 CY2025: Beats On Revenue", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTFBsODcwQVRHaTJwdUhOQUdGX05rZmRWRVg4LUYzNU56cHFVOUw4a2t2UFZ3ODFCSTVhQTBiYTFiWkE0T3l3SFFIWkktSExNN1MtSVRhZUZTRGtYWElyVXRieHZRbDVoaHlsaWVCVWVwWjFGTUhjSHZ2UXRMVjc?oc=5", "source_name": "Market source", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical sets Feb. 19 call to review Q4 2025 results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPRzc2YkVuU2xXZWtJTnFFZ2N5d1Q3VjFtMnRIVUROVERRXzB2bXQ1eWJVV09tTTVkUFF4bGVLTndCbllNMDJ2b0l1UDVCS3FteHZ0aW1xMk5tRnZzWnFZbl84REF1MTlyVjJCeTJmX3JjdkM5ZHQtOHBhYlBrMUlWY3hsSUZheWR3ZE9rY1NnelRBWGVVbWcyZENWdmtsYURkUmFSM2ltNXZqR0kzWEx3b01Nbw?oc=5", "source_name": "Stock Titan", "published_at": "2026-02-05T08:00:00+00:00", "published_display": "05 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Analyst Report: ICU Medical, Inc.", "summary": "", "url": "https://finance.yahoo.com/m/111bf1e1-524c-35e6-8dc9-ad87ea4d3556/analyst-report%3A-icu-medical%2C.html", "source_name": "Morningstar Research", "published_at": "2026-07-16T18:36:29+00:00", "published_display": "16 Jul 2026 18:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical stock hits 52-week high at 162.53 USD By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPeWh0bjEwTWtaSTM3Mjk1aVF2SThRbkxFSDhPakZkanEycHA1dmpOZjNfLUN6anNRTUJZcDM5SkxMTzBRcndYREFlSVc5eUNxOVMxWnhLcFByN2NWZUJtdnBOUjdLalZIYUZuVkhRTXg3eWRJV3dRYXpMdVdHeWxNNDFHY29zSjFTdXVUZXI2TWExM3cyeFR1MElLZDlsNmJMNlR4NjhYSkk4S3pM?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-16T17:42:53+00:00", "published_display": "16 Jul 2026 17:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Improved Focus and More-Profitable Business Mix Narrate No-Moat ICU Medical's Turnaround Story", "summary": "ICU Medical, originating as an infusion consumables supplier, diversified its product portfolio through key acquisitions, notably Hospira Infusion Systems in 2017 and Smiths Medical in 2022. These strategic moves broadened its offerings to include infusion pumps and IV solutions,", "url": "https://www.morningstar.com/company-reports/1488122-improved-focus-and-more-profitable-business-mix-narrate-no-moat-icu-medicals-turnaround-story", "source_name": "Morningstar", "published_at": "2026-07-16T18:11:03", "published_display": "16 Jul 2026 18:11", "sentiment": "positive", "sentiment_pct": 74, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical stock hits 52-week high at 162.53 USD", "summary": "ICU Medical Inc. (ICUI) stock reached a new 52-week high of $162.18, reflecting a significant 27.93% increase over the past year. InvestingPro analysis suggests the stock is currently undervalued, with a PEG ratio of 0.57, highlighting strong investor confidence and growth potent", "url": "https://www.investing.com/news/company-news/icu-medical-stock-hits-52week-high-at-16253-usd-93CH-4796028", "source_name": "Investing.com", "published_at": "2026-07-16T13:42:41", "published_display": "16 Jul 2026 13:42", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will US$500 Million Non-DEHP IV Expansion in Texas Change ICU Medical's (ICUI) Narrative", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxPVk05cTJyX1Fkd1k1aURERExHWWZ3TW4td0dabUUtcGMzc0dwTnJDOFhQTXJtZUY4dFNTRDVncTNZQ3RUX3V1NW93aHprRDhmS0hTNHBqdWMxN2RQWGZUU2pNbHkzWnNUMGR0cnNtdkFTdkdyNjA3OUV1OU9VY0ZTRDFKTjNSNkJUcUVPRDd6UVB6MEdJUUdTYUg2QmFYd0dCWXpiZEhVSFRNTTJERV90ZlJxOXRnVVRSNUUwVEF1dTAzdXhHc2d1SDNLQ2jSAdIBQVVfeXFMUHhXYnVFakMyZkNBcXJsSVl3LXRkcW9CR3N3d2locVd1a1MzbFNDYXotVEo4UzRIR2puNzY0cjVEOXl3VVExekxkaFcwRFV1SGdEazJmUFZjNjN2UjNUYVA5cFh6T3YzMzRCYVpKS2djZFN6cURpWTJDeURuWWM0R01vb3RaTk1jMVhtT1lCWHpUNG5xQnRFa2tRb3Q1eVBvQnBmRWNwaEJvOTdUTm9wT0dwdHZuZ09INjBOa0UxSkRCLUp3LXRCUE5Ta2VPRnRzelJB?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-15T20:47:51+00:00", "published_display": "15 Jul 2026 20:47", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pharmaceutical venture announces $500M expansion in Northwest Austin", "summary": "Otsuka ICU Medical LLC is investing $500 million to expand its manufacturing facilities in Austin. This expansion includes a new 500,000-square-foot facility and upgrades to its existing 700,000-square-foot site, aiming to improve the long-term supply of IV solutions and support ", "url": "https://communityimpact.com/northwest-austin/development/pharmaceutical-venture-announces-500m-expansion-in-northwest-austin/", "source_name": "Community Impact", "published_at": "2026-07-14T03:12:22", "published_display": "14 Jul 2026 03:12", "sentiment": "positive", "sentiment_pct": 72, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (ICUI) Short Interest & Short Float | Updated Jul 2026 $ICUI", "summary": "As of June 30, 2026, ICU Medical (ICUI) had a short interest of 1.69 million shares, marking a 4.94% decrease from the previous report, representing 6.89% of the public float. The short interest ratio is 4.6 days to cover, indicating it would take 4.6 days to cover all short posi", "url": "https://www.marketbeat.com/stocks/NASDAQ/ICUI/short-interest/", "source_name": "MarketBeat", "published_at": "2026-07-10T18:40:08", "published_display": "10 Jul 2026 18:40", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Otsuka ICU Medical outlays $500m to expand US manufacturing footprint", "summary": "Otsuka ICU Medical is investing $500 million to expand its US-based IV manufacturing capabilities, including a new 500,000-square-foot facility and upgrades to an existing 700,000-square-foot site in Austin, Texas. This expansion aims to enhance supply reliability for North Ameri", "url": "https://finance.yahoo.com/healthcare/articles/otsuka-icu-medical-outlays-500m-153152237.html", "source_name": "Market source", "published_at": "2026-07-10T15:40:43", "published_display": "10 Jul 2026 15:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does ICU Medical\u2019s (ICUI) Russell Index Exit Quietly Reshape Its Institutional Ownership Story?", "summary": "ICU Medical (ICUI) was removed from several Russell growth and small-cap indexes in June 2026, which may alter trading flows and reshape its institutional ownership. While the core business of infusion therapies remains, the company faces ongoing regulatory risks and product reca", "url": "https://www.sahmcapital.com/news/content/does-icu-medicals-icui-russell-index-exit-quietly-reshape-its-institutional-ownership-story-2026-07-08", "source_name": "Sahm", "published_at": "2026-07-10T05:41:39", "published_display": "10 Jul 2026 05:41", "sentiment": "negative", "sentiment_pct": 37, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical Inc (ICUI) Stock Up 3.2% but GF Value Says Overvalued -- GF Score: 80/100", "summary": "ICU Medical Inc (ICUI) stock rose 3.2% to $156.52, but GuruFocus' GF Value\u2122 indicates it is 30.1% overvalued with an intrinsic value of $120.31. Despite a strong GF Score\u2122 of 80/100, highlighting good profitability and growth, its financial strength and valuation ranks are modera", "url": "https://www.gurufocus.com/news/8952715/icu-medical-inc-icui-stock-up-32-but-gf-value-says-overvalued-gf-score-80100", "source_name": "GuruFocus", "published_at": "2026-07-09T23:40:24", "published_display": "09 Jul 2026 23:40", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Otsuka ICU Medical LLC Announces Over $500M Expansion of IV Solutions Manufacturing in North America", "summary": "Otsuka ICU Medical LLC is investing over $500 million to expand its IV solutions manufacturing in North America, with a new 500,000-square-foot facility and upgrades to existing operations in Austin, Texas. This expansion aims to enhance supply chain resiliency, accelerate the de", "url": "https://www.tradingview.com/news/prnewswire:a6f67f13363f4:0-otsuka-icu-medical-llc-announces-over-500m-expansion-of-iv-solutions-manufacturing-in-north-america/", "source_name": "TradingView", "published_at": "2026-07-09T16:40:43", "published_display": "09 Jul 2026 16:40", "sentiment": "positive", "sentiment_pct": 74, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Otsuka ICU Medical LLC Announces Over $500 Million Expansion Of IV Solutions Manufacturing In North America", "summary": "Otsuka ICU Medical LLC is investing over $500 million to expand its North American IV solutions manufacturing capabilities, including a new 500,000-square-foot facility in Austin, Texas, and upgrades to existing operations. This expansion aims to enhance supply resiliency, accele", "url": "https://www.marketscreener.com/news/otsuka-icu-medical-llc-announces-over-500-million-expansion-of-iv-solutions-manufacturing-in-north-ce7f5ededb89ff2d", "source_name": "www.marketscreener.com", "published_at": "2026-07-09T14:10:42", "published_display": "09 Jul 2026 14:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Otsuka ICU Medical announces $500M+ Texas manufacturing expansion", "summary": "Otsuka ICU Medical LLC is investing over $500 million to expand its manufacturing operations in Austin, Texas, adding a new 500,000-square-foot facility to increase production of intravenous solutions and support non-DEHP IV solution development for North America. This expansion,", "url": "https://www.investing.com/news/company-news/otsuka-icu-medical-announces-500m-texas-manufacturing-expansion-93CH-4784115", "source_name": "Investing.com", "published_at": "2026-07-09T13:10:42", "published_display": "09 Jul 2026 13:10", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How ICU Medical plans to shore up U.S. IV solution supply", "summary": "Otsuka ICU Medical LLC, a joint venture involving ICU Medical (Nasdaq: ICUI), announced a $500 million expansion for its IV solutions manufacturing in Austin, Texas. This investment includes a new 500,000-square-foot facility and upgrades to the existing 700,000-square-foot site,", "url": "https://www.stocktitan.net/news/ICUI/otsuka-icu-medical-llc-announces-over-500m-expansion-of-iv-solutions-b1nm4h5g4icb.html", "source_name": "Stock Titan", "published_at": "2026-07-09T12:10:42", "published_display": "09 Jul 2026 12:10", "sentiment": "positive", "sentiment_pct": 73, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Responsive Playbooks and the ICUI Inflection", "summary": "This article analyzes Icu Medical Inc. (NASDAQ: ICUI) with a focus on its near, mid, and long-term sentiment and potential price movements. Utilizing AI models, it outlines distinct trading strategies including position, momentum breakout, and risk hedging, complete with entry zo", "url": "https://news.stocktradersdaily.com/news_release/139/Responsive_Playbooks_and_the_ICUI_Inflection_070826022402_1783491842.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-08T02:24:00", "published_display": "08 Jul 2026 02:24", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is ICU Medical (ICUI) Undervalued As Russell Index Removal Triggers Rebalancing?", "summary": "ICU Medical (ICUI) was recently removed from several Russell growth indexes, prompting a re-evaluation of its stock. Despite this, the stock has shown recent firm trading and is considered undervalued by some metrics, with an intrinsic discount and an average analyst price target", "url": "https://www.sahmcapital.com/news/content/is-icu-medical-icui-undervalued-as-russell-index-removal-triggers-rebalancing-2026-07-06", "source_name": "Sahm", "published_at": "2026-07-06T16:40:43", "published_display": "06 Jul 2026 16:40", "sentiment": "positive", "sentiment_pct": 63, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical Inc business profile and stock context", "summary": "ICU Medical Inc is a global medical technology company listed on Nasdaq, specializing in the design, manufacture, and sale of infusion systems and medical devices used in hospitals and clinical settings. The company focuses on improving the safety and efficiency of intravenous th", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/icu-medical-inc-business-profile-and-stock-context/69683033", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-03T20:40:25", "published_display": "03 Jul 2026 20:40", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of ICU Medical, Inc. \u2013 NASDAQ:ICUI", "summary": "This article displays the \"Price to book forward\" financial metric for ICU Medical, Inc. (NASDAQ: ICUI) on TradingView. It presents a value and change percentage for this specific period. The content is primarily a data display page rather than an analytical article.", "url": "https://www.tradingview.com/symbols/NASDAQ-ICUI/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-30T16:13:53", "published_display": "30 Jun 2026 16:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does ICU Medical\u2019s (ICUI) Russell Growth Exit Hint at a Shifting Long-Term Portfolio Role?", "summary": "ICU Medical, Inc. (ICUI) was removed from several Russell growth indices in late June 2026, which could impact its trading volume and portfolio positioning for growth-focused funds. While this creates short-term noise, the company's investment narrative still centers on long-term", "url": "https://www.sahmcapital.com/news/content/does-icu-medicals-icui-russell-growth-exit-hint-at-a-shifting-long-term-portfolio-role-2026-06-29", "source_name": "Sahm", "published_at": "2026-06-30T16:13:53", "published_display": "30 Jun 2026 16:13", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of ICU Medical, Inc. \u2013 NASDAQ:ICUI", "summary": "This article displays the forward price-to-sales ratio for ICU Medical, Inc. (NASDAQ: ICUI). It presents the current value and its change over a period, accessible through TradingView. The content primarily focuses on financial data for the company.", "url": "https://www.tradingview.com/symbols/NASDAQ-ICUI/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T19:10:56", "published_display": "27 Jun 2026 19:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of ICU Medical, Inc. \u2013 NASDAQ:ICUI", "summary": "This article provides the forward price-to-earnings ratio for ICU Medical, Inc. (NASDAQ: ICUI). It is presented as part of a financial overview on TradingView, indicating the company's valuation based on future earnings estimates. The content itself is very brief, showing \"Period", "url": "https://www.tradingview.com/symbols/NASDAQ-ICUI/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T10:10:56", "published_display": "27 Jun 2026 10:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of ICU Medical, Inc. \u2013 DUS:IC7", "summary": "This article provides financial data for ICU Medical, Inc. under the stock symbol IC7 on the Dusseldorf Stock Exchange. It specifically highlights the \"Price to earnings forward\" metric. The page is part of a larger financial data platform by TradingView.", "url": "https://www.tradingview.com/symbols/DUS-IC7/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T08:40:08", "published_display": "27 Jun 2026 08:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of ICU Medical, Inc. \u2013 NASDAQ:ICUI", "summary": "This article provides the enterprise value to EBITDA forward for ICU Medical, Inc. (NASDAQ: ICUI). It appears to be a financial data point from TradingView, indicating a specific valuation metric for the company. The page focuses on the financial data rather than providing a deta", "url": "https://www.tradingview.com/symbols/NASDAQ-ICUI/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T06:40:08", "published_display": "27 Jun 2026 06:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Understanding the Setup: (ICUI) and Scalable Risk", "summary": "Icu Medical Inc. (NASDAQ: ICUI) is exhibiting a mid-channel oscillation pattern with strong near and mid-term sentiment that could extend long-term. An exceptional 35.6:1 risk-reward short setup targets a 10.4% downside with only 0.3% risk. AI models have generated distinct tradi", "url": "https://news.stocktradersdaily.com/news_release/149/Understanding_the_Setup:_ICUI_and_Scalable_Risk_062726011601_1782537361.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-27T01:40:08", "published_display": "27 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICUI Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for ICU Medical, Inc. (ICUI), detailing analyst opinions, historical stock performance, and key financial metrics. It highlights the current stock price, volatility, market capitalization, and upcoming earnings report, along with ", "url": "https://www.tradingview.com/symbols/NASDAQ-ICUI/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T12:39:25", "published_display": "26 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (ICUI) Stock Forum and Discussion", "summary": "This document appears to be a stub or an empty placeholder for a stock forum and discussion about ICU Medical (ICUI). There is no actual content provided beyond the title. The purpose is likely to host future discussions or information related to ICUI stock.", "url": "https://www.moomoo.com/stock/ICUI-US/community?chain_id=Name1K9-3FXPhg.1kvafk0&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A59,%22f%22%3A%22www.moomoo.com%2Foptions%2FSHEL260501P50000-US%22%7D", "source_name": "Moomoo", "published_at": "2026-06-25T13:10:39", "published_display": "25 Jun 2026 13:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (ICUI): Buy, Sell, or Hold Post Q1 Earnings?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxPUnM3WjBFYzVySERDVmI0TjFlTC13anlITGhUZTQ3Um9Fam9haWEyZzVCZUZRbUZ4d2hxYjgyU1YyMTVtVGVUOW1FZFB6bkpCMXRTMGJsLW1DSGRDM3VHTW5aeG5nbXZYVHBLRHk0VHdReGFhaXVqckpEdzliMjY2dWJBdm44alBfMjlPSlpfRzBtM3Jn?oc=5", "source_name": "Market source", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Moody\u2019s upgrades ICU Medical rating to Ba3 on leverage outlook By Investing.com", "summary": "Moody's Ratings has upgraded ICU Medical, Inc. (NASDAQ:ICUI) to Ba3 from B1, anticipating a decline in the company's financial leverage over the next 12 months. This upgrade is based on expectations of adjusted debt to EBITDA remaining below 4.0x, driven by revenue growth, strong", "url": "https://ng.investing.com/news/stock-market-news/moodys-upgrades-icu-medical-rating-to-ba3-on-leverage-outlook-93CH-2563649", "source_name": "Investing.com Nigeria", "published_at": "2026-06-17T20:50:00", "published_display": "17 Jun 2026 20:50", "sentiment": "positive", "sentiment_pct": 72, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BTIG Initiates ICU Medical at Buy With $170 Price Target", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/btig-initiates-icu-medical-buy-102610105.html", "source_name": "MT Newswires", "published_at": "2026-06-15T10:26:10+00:00", "published_display": "15 Jun 2026 10:26", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (ICUI) Stock Valuation Check After Recent Momentum And Discount To Estimated Fair Value", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQeDZjdVU3Ulh0dHViWVpRdk1OdnpFSlhkZjZwMTdSeUdBdVBYSWN0ZGFEZHFEaVk4UmsybW1uRklVZmtoZ19UMFhsLUZvZTVyWUlVbDZwNmFBT1N2UExGMkVnZ0pCNVFtMlZBZ3M5SGc2UDY4Qm9DYnpoUHdJeThScTVlUnY5Q05PdGdsXzh0YlZ4MWpOUDMzZVFQMlJRZw?oc=5", "source_name": "Market source", "published_at": "2026-06-14T07:00:00+00:00", "published_display": "14 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (ICUI) Strengthens Amid Competitors\u2019 Quality Issues", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxORzhuU1JwQmdYRnFYX2pma2VVa0lmN29sbVpuZTBKYkJ5d2xMQmJDM2RUOWd5Tk0tOTBLay12SjVkSUd0c3BiUWhsTFF1ZWpDUmlsWFkyTWxxdzVacTE5cVhHcmxzZEMwaU9CMDQ0QlQxb1QwU01PeHRoZVFlSGxDLUJwVWJxU1hyMUlxYXlEbEkyV3dxeExVVUk5X0JLVTJsZFlaZg?oc=5", "source_name": "Market source", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (ICUI) VP and General Counsel Sanzone sells 2,447 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOaTV3c0p3WmpMcTczalBSVjBjeXRHOGtNdHBBWU5vRmV6N1ViN25yVnFZRjAzRjVySW4wcUJzVG9BU1h3ZHpJTEdzU2dkYzJwUnJKb0Q5OC1IRkR4Y2RHcC1XTi1KMXRpWTNsMVI0cV8tcjBFNzI5akJuUkotTGRqQS1OODZPZ1ZITHVJUVRrQzRjTkgtbWxMNDU0SDNFcWNoazZFa0ttNm1PUDZCc3JIUkh3?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical's (NASDAQ:ICUI) Shareholders May Want To Dig Deeper Than Statutory Profit", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNWUdKNlF5SGQwa3M1R1Q3X2daV3FSSlhob0JrbHY1MXMxekc3WVdyczg2YzhVZWVOZTRWU0htRnZXc2w2NUE2QVRfT1E3cjJ4VGRjdXhTeUtfdVlVejh6ZlNUaG5tVURDWWRCMmtaZlZINGxSQlhwQ0VFM1VvOC01UFg0V1AtTW8wMzdHd3llakJoQzNX?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should ICU Medical\u2019s Q1 Earnings Beat And Return To Profitability Require Action From ICUI Investors?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPV3k5WUYzRnpQaGFYdTRLTWhEZE9OU19RVHVoX1J5V2VoR3JHTmc2YjFlTG5UWnJrNWNOT2JJbkdUT2FlendFV2g2eFFzN2t5TFktT2JjYjFHUXM1YzVidlNPNHRxaEd0SU9LZmdYRlBtT3J5SGV2MnNScUx1bFdlY19wcm1xTFNuczlxcERWbVFGUUc4RGNTaw?oc=5", "source_name": "Market source", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (ICUI) Margins Return To Breakeven Trailing Profit Challenging Bearish Narratives", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxOUnNHUlB4WEhtNlNzMFg3VHhXcmhjalU4eGhadFEyMUlDNUlIWDVqcWRhVVNEdlhKYjJmVDRPMmxwV2VxeGFBRU5HWTFTVGNuMkJTSnNIcGc2cUpDTG4wMExGQmVUREZuYzB1NkdJRFAtRU9hTTEwWm9OQTBVS0NMTVV3YzA0T3hPbzBxeWZHUWxmdmRXZFNaRUZrWWZKVG9QZ2NCOU9Ta00tVE5GSjVkcXN0WVU4M1Y4Ny1TYTZ1WlNhNEJVXy00UF95Vm_SAdIBQVVfeXFMT2xSeEJzSTNFNGY3Tm5GbjZUbXVEZEFodDRXSkREbzVMQUlGei00M01BdFU4NG9MRmdCbnZtWjZhSWNnUjlyQVM5QzFqd2E5WkRCYjJURV84T2haSFkxT2hPTmtVUWVrWEgwclJWNDdhSmxEcTU3UEVMeEZ1ZkdiczBRbFdkekVUV1Q2dktxOGl0b21KSVp3c3EtVjZ6OC10WVZxQUM1REltS1ZCMFBwUUowSDM5c2tWRFY0bWVzSE1VUzlpdVJYb3dCLWZ3REVVVUln?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (NASDAQ:ICUI) Exceeds Q1 CY2026 Expectations", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPdkV3eUQ2SDdXUjdvLTRIOTNnV1FHNmJGNGw3S2taN25jZzU4dmR2NjJwQnhBal9tbHFtbGVLODhDMnlEWm9hNmpKbXgxQnVoU0NEZkFEUW90ZGp6RWxGUm0zV1FfQVhtc3FiNG54Y0V3MktXci1mcnBGTmkySk9XTEFtaTF6d0JrRUE5OTlKNVJjQlptYko4bzdPVkVXZzA0WjREQkFnT25kbGc2dzZMYi1R?oc=5", "source_name": "StockStory", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (ICUI) Tops Q1 Earnings and Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOMHZhOWJhTGNOYlFHazhRaW1Cb3I1M01IQVFrZExhRk8tTWk3QmM3MFFnSXBGV1lIRXIxeVluRk1EaERHdTUzVHRZSEFyRzZLVmJCRVJlS0RTWlFyakRqNWExVDUzSm1ZUWxVZkxSdzdmWk5HV1o0MzQwY2d1S1RGUTBjOTlNeVc3dkQwd2NyYk9VMFZEUmt6LQ?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical (ICUI) Reports Next Week: Wall Street Expects Earnings Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQbzBJT3c3X3RKczlqVkpoLVY4MGdVZXN4VnlnWkZycWx3XzdiVlNhTTNaTjE3N005TGJEWVgyNTM0d2hVYTlsdUQxZU1za1pHVm5SR3pkWUtyaHMyU3VVSWJsWXhKVWMydllsVjYtdG41aWpDX3MzR0RWa2pxNXRBcldaMDFrWk1sVnpKb21xRnlYUzFROUpmbDN3?oc=5", "source_name": "Market source", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical posts first-quarter results May 7; call starts at 4:30 ET", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNMzRBRVFNRERXZDItVy1VWjZKSEtVOHhxeGdDMDQwbGlVeF92R3hxVE5VU2pGanNQcE9tM3hja0RocjJma3JSaWJfTmxvdXBLWG1mMnQwQmtPVDcwMkJCNEZnVHhxMVNmWjlYWUhiMXBWSjc2Q2hJUGtManFGaV90WXh0S3ZmTExfbm1xWVFlRWJld01jV3BrNFlwdWtLR0w3U3MydnJOTGZ2Tk9wdDZHR1VOcW5hSm1CM1p6ZDZ4ck4?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The ICU Medical (ICUI) Investment Story Is Evolving With 2026 Guidance And Analyst Targets", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNbjZJTWNZcnZmbnJhMXRPOWFMMFNuQ2xYQ3o3N1hDUTVuNVdicDNPeGxMdkl4ZFNiV08zNGY3OXFfOVFuU3diRXZCSTZ4NUVzVHd0blNSYWwwXzVxUzJoV3J4RUdCUkdfNnJQeURoUEhCNnBITHc2dk5FVXNGWkxIcEZ4dm9lSHU4QzQ1Y2lBaXMwS1AzQWNiM3B1dFBUdmc?oc=5", "source_name": "Market source", "published_at": "2026-03-22T07:00:00+00:00", "published_display": "22 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical Confronts Revenue Strain As Valuation Signals Potential Upside", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-13T07:00:00+00:00", "published_display": "13 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Healthcare Stocks Review 2026: ICU Medical vs. Intuitive Surgical vs. Medpace - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNM0RhNGlxVnltcFNaeDQ1cGV0YThXYm1GWmVUVWxocmFUTVh0eFJWSmFDaTJkSE9sbjhrYjNRVUFfTFE2M0h2SDRwZ0pEYld5MjRVRlJlMER0VUN6M2dJei1GbEtRWHdXSzd5LVBhd1FMYmpVQXlVUkRKdDFISDY5b240dWtCTndGcW1Kck1xN0xpb1N6NmJqTkxxWFEtcHZK?oc=5", "source_name": "IndexBox", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical\u2019s (NASDAQ:ICUI) Q4 CY2025: Beats On Revenue", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTFBsODcwQVRHaTJwdUhOQUdGX05rZmRWRVg4LUYzNU56cHFVOUw4a2t2UFZ3ODFCSTVhQTBiYTFiWkE0T3l3SFFIWkktSExNN1MtSVRhZUZTRGtYWElyVXRieHZRbDVoaHlsaWVCVWVwWjFGTUhjSHZ2UXRMVjc?oc=5", "source_name": "Market source", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICU Medical sets Feb. 19 call to review Q4 2025 results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPRzc2YkVuU2xXZWtJTnFFZ2N5d1Q3VjFtMnRIVUROVERRXzB2bXQ1eWJVV09tTTVkUFF4bGVLTndCbllNMDJ2b0l1UDVCS3FteHZ0aW1xMk5tRnZzWnFZbl84REF1MTlyVjJCeTJmX3JjdkM5ZHQtOHBhYlBrMUlWY3hsSUZheWR3ZE9rY1NnelRBWGVVbWcyZENWdmtsYURkUmFSM2ltNXZqR0kzWEx3b01Nbw?oc=5", "source_name": "Stock Titan", "published_at": "2026-02-05T08:00:00+00:00", "published_display": "05 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 83, "total_relevant": 46, "sentiment_summary": {"positive": 23, "negative": 3, "neutral": 20, "score": 58, "total": 46, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 74, "events": [{"event": "general", "label": "Market update", "weight": 10.45, "count": 19}, {"event": "earnings", "label": "Earnings", "weight": 7.15, "count": 13}, {"event": "analyst", "label": "Analyst action", "weight": 3.65, "count": 6}, {"event": "macro", "label": "Macro sensitivity", "weight": 2.75, "count": 5}, {"event": "deals", "label": "Deals and strategy", "weight": 0.9, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 23, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 154.42, "latest_week": "2026-07-10", "one_week_move": -0.4, "four_week_move": 8.6, "twelve_week_move": 18.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.915305, "market_dynamics_buy_signal": false, "relative_strength": -1.819772, "fair_value_gap": 16.4, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 54.5633, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.4% over one week, +8.6% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 56, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 10}, {"label": "TradingView", "count": 7}, {"label": "simplywall.st", "count": 4}, {"label": "Stock Titan", "count": 4}, {"label": "Sahm", "count": 3}, {"label": "Investing.com Nigeria", "count": 2}, {"label": "Investing.com", "count": 2}, {"label": "Stock Traders Daily", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 46}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 19}, {"label": "Earnings", "count": 13}, {"label": "Analyst action", "count": 6}, {"label": "Macro sensitivity", "count": 5}, {"label": "Deals and strategy", "count": 1}, {"label": "Regulatory and legal", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "58/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "74/100 classification confidence."}, {"label": "Company focus", "value": "46", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-0.4% over one week, +8.6% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Analyst Report: ICU Medical, Inc."}], "updated_at": "2026-07-17T13:31:28.769092+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}